CBL performs clinical manufacturing for all regulatory phases. Contracting with CBL for clinical manufacturing has a number of advantages:

1. Because clinical drug substances are frequently expensive and difficult to obtain in quantity, CBL has systems designed to minimize losses, ensuring customers get the maximum amount of finished product possible.
2. CBL has a large selection of pre-qualified vials, stoppers and syringes. Choosing one of the CBL pre-qualified combinations can reduce the time from project initiation to production to two months in most cases.
3. CBL can fill liquid or lyophilized products in vial sizes from 3cc to 100cc and most major syringe sizes.
4. CBL has commercial scale manufacturing and a regulatory profile including approvals by regulatory agencies in multiple countries, allowing for growth and scale-up opportunities as your product progresses through to regulatory approval and commercial distribution.